UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054379
Receipt number R000062011
Scientific Title Clinical study on the effect of a desktop humidifier on tear film
Date of disclosure of the study information 2024/05/12
Last modified on 2024/05/12 22:35:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety and efficacy of photocatalytic micro-mist desktop humidifier for dry eye caused by digital environment

Acronym

Clinical Study on the Influence of a Desktop Humidifier on tear film

Scientific Title

Clinical study on the effect of a desktop humidifier on tear film

Scientific Title:Acronym

Effect of a desktop humidifier on tear film

Region

Japan


Condition

Condition

dry eye

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examining the effect of micro-mist from a desktop humidifier on the tear film of VDT workers

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Immediately before humidifier, immediately after 1-hour VDT work with humidifier, 1.5 hours after humidifier and VDT work

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Humidifier mist for 1 hour for VDT workers

Interventions/Control_2

VDT work without mist

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

The subjects of this study will be those whose written consent to participate in this study has been obtained and who meet all of the following criteria
1) Age: 18 years old or older, but not older than 70 years old at the time consent is obtained
2) Gender: Not applicable
3) Able to fill out the consent form in their own handwriting

Key exclusion criteria

Any of the following will be excluded from the study.

Exclusion Criteria
1) Patients with acute ocular or eyelid disease
2) Patients with obvious eyelid or ocular surface disease (eyelid congenital anomalies, entropion, ectropion, Sjogren's syndrome)
3) Anti-glaucoma eye drops
4) Previous ocular surgery within 3 months, Intense pulsed light (IPL) therapy, LipiFlow, Botox injections
5) Ocular allergy symptoms at the time of examination
6) Deemed ineligible by the principal investigator or research associate

Target sample size

32


Research contact person

Name of lead principal investigator

1st name Reiko
Middle name
Last name Arita

Organization

Itoh Clinic

Division name

Ophthalmology

Zip code

3370042

Address

626-11, Minaminakano, Minumaku, Saitama City, Saitama

TEL

0486865588

Email

ritoh@za2.so-net.ne.jp


Public contact

Name of contact person

1st name Reiko
Middle name
Last name Arita

Organization

Itoh Clinic

Division name

Ophthalmology

Zip code

3370042

Address

626-11, Minaminakano, Minumaku, Saitama City, Saitama

TEL

0486865588

Homepage URL


Email

ritoh@za2.so-net.ne.jp


Sponsor or person

Institute

Itoh Clinic

Institute

Department

Personal name



Funding Source

Organization

Kaltech Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamauchi Clinic

Address

1-15-19, Jiyugaoka, Meguroku, Tokyo

Tel

03-3723-7717

Email

fujii.tetsuya@neues.co.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2023-09-00202

Org. issuing International ID_1

Yamauchi Clinic

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

伊藤医院


Other administrative information

Date of disclosure of the study information

2024 Year 05 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

31

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 08 Month 23 Day

Date of IRB

2023 Year 09 Month 25 Day

Anticipated trial start date

2023 Year 09 Month 26 Day

Last follow-up date

2023 Year 10 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 05 Month 12 Day

Last modified on

2024 Year 05 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062011